Terms: = Lymphoma AND CNTRL, CEP1, CEP110, 11064, ENSG00000119397
9 results:
1. Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.
Tan KW; Zhu YY; Qiu QC; Wang M; Shen HJ; Huang SM; Cao HY; Wan CL; Li YY; Dai HP; Xue SL
Ann Hematol; 2023 Sep; 102(9):2397-2402. PubMed ID: 37103615
[TBL] [Abstract] [Full Text] [Related]
2. Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan.
Hsu YC; Yu CH; Chen YM; Roberts KG; Ni YL; Lin KH; Jou ST; Lu MY; Chen SH; Wu KH; Chang HH; Lin DT; Lin SW; Lin ZS; Chiu WT; Chang CC; Ho BC; Mullighan CG; Yu SL; Yang YL
Sci Rep; 2021 Mar; 11(1):5802. PubMed ID: 33707599
[TBL] [Abstract] [Full Text] [Related]
3. [8p11 myeloproliferative syndrome cured by allogeneic hematopoietic stem cell transplantation: two case reports and literature review].
Xu LP; Chen Y; Shi HX; Huang XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):993-6. PubMed ID: 24343089
[TBL] [Abstract] [Full Text] [Related]
4. Dysregulated signaling pathways in the development of cntrl-FGFR1-induced myeloid and lymphoid malignancies associated with FGFR1 in human and mouse models.
Ren M; Qin H; Kitamura E; Cowell JK
Blood; 2013 Aug; 122(6):1007-16. PubMed ID: 23777766
[TBL] [Abstract] [Full Text] [Related]
5. Myeloproliferative disorders with t(8;9)(p12;q33): a case report and review of the literature.
Hu S; He Y; Zhu X; Li J; He H
Pediatr Hematol Oncol; 2011 Mar; 28(2):140-6. PubMed ID: 21214407
[TBL] [Abstract] [Full Text] [Related]
6. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), cep110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
[TBL] [Abstract] [Full Text] [Related]
7. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
Macdonald D; Reiter A; Cross NC
Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
[TBL] [Abstract] [Full Text] [Related]
8. Identification of four new translocations involving FGFR1 in myeloid disorders.
Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
[TBL] [Abstract] [Full Text] [Related]
9. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
[TBL] [Abstract] [Full Text] [Related]
